Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life
Idioma
EN
Article de revue
Este ítem está publicado en
Erj Open Research. 2024-07-08, vol. 10, n° 4, p. 00976-2023
Resumen en inglés
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, ...Leer más >
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, their asthma being under control. https://bit.ly/49ixpxt.< Leer menos
Centros de investigación